First Tracks Biotherapeutics, Inc. (TRAX)

Market Cap	639.38M
Revenue (ttm)	n/a
Net Income	n/a
EPS	n/a
Shares Out	34.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	184,580
Open	20.51
Previous Close	22.51
Day's Range	14.79 - 21.00
52-Week Range	15.61 - 26.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About TRAX

First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.

• Founded: 2025
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: TRAX